Clinical Trial Simulations

Applications and Trends

  • Holly H. C. Kimko
  • Carl C. Peck
Part of the AAPS Advances in the Pharmaceutical Sciences Series book series (AAPS, volume 1)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Application of M&S in Regulatory Decisions

    1. Front Matter
      Pages 13-13
  3. Clinical Trial Simulation and Quantitative Pharmacology

    1. Carl C. Peck, Holly H. C. Kimko
      Pages 1-11
  4. Application of M&S in Regulatory Decisions

    1. Front Matter
      Pages 13-13
    2. Siv Jönsson, Anja Henningsson, Monica Edholm, Tomas Salmonson
      Pages 15-36
    3. Christine E. Garnett, Joo Yeon Lee, Jogarao V. S. Gobburu
      Pages 37-57
  5. Strategic Applications of M&S in Drug Development

    1. Front Matter
      Pages 59-59
    2. Mike K. Smith, Jonathan L. French, Kenneth G. Kowalski, Matthew M. Hutmacher, Wayne Ewy
      Pages 61-83
    3. Timothy J. Carrothers, F. Lee Hodge, Robert J. Korsan, William B. Poland, Kevin H. Dykstra
      Pages 85-107
    4. José C. Pinheiro, Frank Bretz, Chyi-Hung Hsu
      Pages 109-130
    5. Anthe S. Zandvliet, Rik de Greef, Anton F. J. de Haan, Pieta C. IJzerman-Boon, Maya Z. Marintcheva-Petrova, Bernadette M. J. L. Mannaerts et al.
      Pages 131-148
    6. Ene I. Ette, Christopher J. Godfrey
      Pages 149-172
  6. Application of M&S in Selected Therapeutic Areas

About this book

Introduction

This edition presents a review of the principles and progress surrounding clinical trial simulations (CTS), along with case studies illustrating CTS in various therapeutic and application areas.  In addition, the book expands on the utility of CTS for informing decisions during drug development and regulatory review. Each chapter has been written by esteemed authors who have demonstrated expertise in state-of-the-art application of CTS. 

The target audience for the volume includes researchers and scientists who wish to consider use of simulations in the design, analysis, regulatory review or guidance of clinical trials, and academic researchers and others working in drug development (e.g., clinicians, senior managers, project planning and regulatory affairs professionals). The focus is on the effective utilization  of CTS in decision mechanisms. Readers will gain broad knowledge on how CTS can improve the efficiency, informativeness, speed and economy of model-based drug development and regulation.

Holly H.C. Kimko, PhD is a senior pharmacometrics leader (Research Fellow) at the Department of Advanced Modeling & Simulation in Johnson & Johnson Pharmaceutical Research & Development, LLC, New Jersey, and Adjunct Professor in the faculty of the Pharmacy School of Rutgers University, New Jersey.  She was previously Assistant Professor in the Center for Drug Development Science in Georgetown University Medical School, Washington DC. Trained in biochemistry and pharmacy, Dr. Kimko earned her Ph.D. degree in Pharmaceutical Science from the State University of New York, Buffalo.  She has published key papers on indirect response modeling and applications of CTS, and co-edited Simulation for Designing Clinical Trials.

Carl C. Peck, MD is Adjunct Professor, Center for Drug Development Science in the Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California San Francisco, California.  He was previously Director of the FDA Center for Drug Evaluation and Research, Assistant U.S. Surgeon General, and President of the American Society for Clinical Pharmacology and Therapeutics.  Dr. Peck has also held professorial appointments in the faculties of UCSF, USUHS, and Georgetown University.  He is an author of more than 150 original research papers, chapters and books concerning advanced concepts and techniques of quantitative pharmacology, trial designs, and pharmaco-statistical modeling and simulation.

Keywords

Application Clinical Kimko Peck Simulation Trend Trial

Editors and affiliations

  • Holly H. C. Kimko
    • 1
  • Carl C. Peck
    • 2
  1. 1.Department of Advanced Modeling & SimulaJanssen Research & Development, LLCRaritanUSA
  2. 2.Dept. Biopharmaceutical SciencesUniversity of California, San FranciscoSan FranciscoUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-4419-7415-0
  • Copyright Information American Association of Pharmaceutical Scientists 2011
  • Publisher Name Springer, New York, NY
  • eBook Packages Biomedical and Life Sciences
  • Print ISBN 978-1-4419-7414-3
  • Online ISBN 978-1-4419-7415-0
  • Series Print ISSN 2210-7371
  • Series Online ISSN 2210-738X
  • About this book